Snahel Patel

Snahel Patel currently serves as Vice President and Head of Chemistry at Frontier Medicines, leading teams in Medicinal, Platform, and Process Chemistry and Compound Management across South San Francisco and Boston labs. With extensive experience in drug discovery, Snahel Patel has held various leadership roles, including Executive Director and Senior Director in medicinal chemistry at Frontier Medicines and Tenaya Therapeutics, where contributions included guiding critical projects such as the clinical compound TN-301. Prior experience spans over two decades at major pharmaceutical companies, including Genentech and Pfizer, focusing on small molecule drug discovery, with early roles in research chemistry at GSK and internships in exploratory chemistry. Snahel Patel's career reflects a strong commitment to developing high-quality therapeutics and fostering a culture of teaching and mentorship in drug discovery.